Omnicell (OMCL) Appoint Edward Bousa to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Omnicell Appoints Edward Bousa to Board of Directors
July 12, 2021 8:31 AM EDTMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has increased its number of board seats from 9 to 10, and has appointed Edward P. Bousa to fill the newest seat of the Companys Board of Directors, effective immediately. Mr. Bousa will serve as an independent director and as a member of the Boards Corporate Governance Committee.
Mr. Bousa is a renowned value portfolio manager who brings nearly four decades of experience in institutional asset... More



